StockNews.com Begins Coverage on Vascular Biogenics (NASDAQ:VBLT)

StockNews.com began coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance NASDAQ VBLT opened at $0.16 on Friday. The business has a 50 day simple moving average of $0.20 and […]

Related Keywords

United States ,Israel , ,Envestnet Asset Management Inc ,Medicard Ltd ,Vascular Biogenics Company Profile ,Vascular Biogenics Ltd ,Advisor Group Holdings Inc ,Renaissance Technologies ,Vascular Biogenics ,Free Report ,Get Free Report ,Sigma Investments ,Asset Management ,Advisor Group Holdings ,Group Holdings ,Biogenics Ltd ,Vascular Biogenics Daily ,Nasdaq Vblt ,Vblt ,Medical ,Initiated Coverage ,Stocknews Com ,